January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Applied Therapeutics, Inc. (NASDAQ: APLT) securities between January 3, 2024 and December 2, 2024, all ...

Sage Therapeutics has a unique approach to targeting GABA, which allows it to target CNS disorders. Read why I think SAGE ...

New York, New York-- (Newsfile Corp. - January 19, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Applied Therapeutics, Inc. (NASDAQ: APLT) between ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

With every new year comes reflection and resolutions. But as we go to press well into January, it is worth a reminder that studies show nearly 90% ...

Discover the potential of macrocycles in drug discovery: flexible, cell-permeable molecules targeting undruggable proteins.

Clinically significant reductions in bleeding underscore abelacimab’s strong potential to address an unmet need for patients ...

PHILADELPHIA - Context Therapeutics Inc. (NASDAQ:CNTX), a company focused on developing treatments for solid tumors, announced the addition of Karen Smith, MD, PhD, MBA, LLM and... Context ...

In a challenging economic environment, ZURA's stock has hit a 52-week low, dropping to $1.75. According to InvestingPro ...

Investors following Cathie Wood's ARK ETFs closely watched as the funds executed a series of trades on Tuesday, January 21, ...